CytoDyn Inc.
CYDY
$0.2265
$0.022511.03%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 86.29% | 73.35% | 72.95% | 37.56% | 64.43% |
| Total Depreciation and Amortization | -48.57% | -50.00% | -72.09% | -83.43% | -87.89% |
| Total Amortization of Deferred Charges | -75.69% | -49.11% | -57.49% | -24.92% | -17.72% |
| Total Other Non-Cash Items | -57.42% | -35.88% | -49.20% | -52.33% | -73.24% |
| Change in Net Operating Assets | -229.85% | -251.51% | -255.92% | 1,075.56% | 16.68% |
| Cash from Operations | 62.71% | 87.18% | 94.35% | 56.26% | 54.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -53.51% | -42.77% | 158.21% | 157.41% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.94% | -66.04% | -62.68% | -64.02% | -77.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 129,812.50% | 1,439.61% | 269.68% | -- | -100.28% |
| Cash from Financing | 35.95% | -19.31% | -22.43% | -60.74% | -73.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 371.36% | 254.55% | 319.64% | -84.10% | -135.29% |